Skip to main content
PLOS One logoLink to PLOS One
. 2026 Feb 19;21(2):e0340006. doi: 10.1371/journal.pone.0340006

Protocol for the ‘exploration of mental well-being, health-related quality of life, and psychosocial outcomes in youths on dialysis in New Zealand: A cross-sectional methods study’

Kavitha Jaganathan 1,#, Anna Serlachius 2,#, Chanel Prestidge 3,‡, Fredric S Doss 4,5,‡, Mark R Marshall 1,6,*,#
Editor: Hansani Madushika Abeywickrama7
PMCID: PMC12919795  PMID: 41712558

Abstract

Introduction

It is well accepted that young individuals on dialysis have poor clinical outcomes, although it is increasing apparent that they have similarly poor patient-centred ones. We study these latter outcomes in the population of youths undergoing dialysis in Aotearoa New Zealand (AoNZ). This study aims to report their sociodemographic and clinical characteristics, and explore their mental well-being and health-related quality of life, and how these outcomes are influenced by factors such as self-efficacy, physical activity, mood, and social anxiety.

Methods

A cross-sectional survey will be conducted of youths aged 15–24 years on dialysis in AoNZ with eligible youths on dialysis across AoNZ, using validated psychometric instruments to assess daily activities, mental health, quality of life, social interactions, and self-efficacy. Open-ended questions within the survey will collect qualitative data. Clinical and demographic data will be established from clinical records and linked public health databases.

Analysis

Quantitative data will be analyzed using descriptive statistics and structural equation modeling to explore associations between psychometric constructs, mental well-being, and quality of life. Open-ended questions will be analysed using qualitative content analysis.

Ethics and Dissemination

Informed consent will be sought from all participants. The research will adhere to data protection guidelines, ensuring that participants’ rights and confidentiality are protected. Results will be disseminated through academic publications, conferences, and summary reports provided to participants and stakeholders.

Introduction

Chronic kidney disease (CKD) is an important health issue of our time [1,2]. It is a major global cause of lost life-years and affects over 850 million individuals [3]. Behind these statistics, there lies profound personal suffering for individuals who reach kidney failure, experiences that are often hard for healthcare professionals to fully appreciate. Amongst the most vulnerable kidney failure populations are classified as youth. Those aged 15–24 years are generally only a small proportion of the total kidney failure population, constituting only 1–2% of the total kidney replacement therapy patient pool in Aotearoa New Zealand (AoNZ) [4]. Even with a small population, however, such patients are a tragedy of missed potential and reduced life-years lived. From a societal perspective, this demographic is associated with a high cumulative cost, both directly from their greater longevity relative to older patients, and also indirectly from lost opportunity cost.

Cumulative clinical experience and medical research shows that the health of all patients with kidney failure is critically dependent on them receiving a timely kidney transplant, since this allows a quantity and quality of life that is closer to that of healthy people, while those remaining on dialysis have unquestionably poorer longevity and patient-centred outcomes [5,6]. Nonetheless, a substantial number of youths have to remain on dialysis, either temporarily as a bridge to transplant or a permanent modality (Fig 1) [7]. The physical and mental health of these individuals is not as well studied as it is in their counterparts receiving a transplant. What data exist suggest poor development of exercise capacity and psychosocial health, often impairing later achievement of vocational, recreational and relationship goals [8–11]. Understanding psychometric causes of these associations might provide an opportunity for intervention to improve the longer-term health status of youths, and benefit society through their greater life participation and community engagement.

Fig 1. Time from onset of kidney failure to primary (first) transplant among incident kidney failure patients in Australia and New Zealand (ANZ) (2003–2022), with competing risk of death Top panel: incident youths aged 15-24 years of age. Lower panel: incident adults 25 years and older.

Fig 1

Courtesy of Feruza Kholmurodova, Biostatistician, Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).

This research aims to investigate the unmet needs in physical and psychosocial health among AoNZ youths undergoing dialysis. From these data, we will model likely relationships between psychometric constructs, physical activity and mental health in this population. Using a survey, we aim to assess the entire youth population on dialysis in AoNZ. We anticipate our results to provide valuable insights into their specific needs and inform the development of targeted interventions to enhance their mental well-being and quality of life (QOL).

Materials and methods

Study design and setting

This observational cross-sectional study will focus on youth on dialysis in AoNZ. Data will be collected without altering or intervening in treatment protocols, emphasizing real-world experiences and outcomes. Patient perceptions and beliefs will be assessed through a survey, supplemented by clinical and demographic data sourced from clinical records and linked public health databases. The study will be conducted in accordance with applicable aspects of Good Clinical Practice guideline [12]. Ethical approval has been granted by the national (NZ) Health and Disability Ethics Committee (21/NTB/125) as well as Institutional Review Boards (IRBs) of all the participating hospitals. All participants will provided informed consent. Patient recruitment started in 13 June 2022 and is expected to be completed during early December of 2025, and data analysis completed and results submitted for publication in early 2026.

Patient and public partnership

To refine the study protocol, we have engaged both public and patients through an iterative process. Feedback has been collected from clinical practitioners and the University of Auckland Health Psychology Research Lab Group, including healthy individuals. The survey was piloted on five young people living with chronic kidney disease, and subtle adjustments made to order and layout. This approach has been adopted to ensure a patient-centered and practical design [13,14].

Study population

Inclusion criteria.

Eligible patients for the study are those aged between 15 and 24 year [15], inclusive, who are currently undergoing dialysis treatment in AoNZ, and able to provide informed consent or assent. Based on the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA, www.anzdata.org.au), there are approximately 50 youths aged 15–24 currently receiving dialysis in Aotearoa New Zealand. We anticipate a recruitment rate of 50–60%, yielding an expected sample size of 25–30 participants.

Exclusion criteria.

Exclusion criteria include patients posing logistic or safety risks while requiring interviewer assistance; those suffering from acute severe medical illness; those with severe functional difficulties or disabilities that are not appropriate for assessment by the survey instrument; those who are unable to give direct informed consent or assent; those outside the specified age range; and those not currently receiving dialysis treatment at the actual time of survey.

Participant recruitment.

Invitations to participate will be made to patients by the University of Auckland (UoA) Research Team, after initial dissemination of information about the research study using letters, posters, texts and emails distributed by clinical staff within dialysis services. Patients agreeing to participate will be asked for their written informed consent and assigned an encrypted identifying code (eID) by local site investigators.

Study procedures

The survey is to be administered as an online, postal, or in-person survey, according to participant preference. Participants will complete the survey independently; however, in rare cases where a participant has a documented cognitive or physical impairment that prevents self-completion, assistance from a parent or caregiver will be permitted. Participants will be asked to complete the survey either within their dialysis facility or at home and given the option of allowing their caring clinical team to access their survey responses. Participants will be given a maximum of 4 weeks to complete the survey. The survey will be conducted electronically using the QualtricsXM Platform™ (Utah, USA) hosted within UoA accredited data centers

An initial version of the survey was created by three authors (KJ, AS, MM) using instruments relevant to the psychosocial challenges faced by young adults and adolescents on dialysis. External experts recommended the inclusion of specific instruments tailored to assess the mental well-being of Māori patients. The survey is structured into eleven sections, each focusing on different aspects of the participants’ daily lives, physical health, overall well-being, quality of life, mental health, ethnic identity, self-efficacy, social situation, mood, health literacy, and general health background.

Some sociodemographic and clinical variables will be collected directly from participants via the survey and but supplemented and reconciled with corresponding data collected by site investigators from the ANZDATA Registry, the National (AoNZ) Kidney Transplant Waiting List, and local electronic medical records.

The hard copy surveys and original datasets will be stored in secured, encrypted repository/folders at study sites, and shared with the UoA Research Team as de-identified data extracts labelled only with eID after removal of all personal identifiers.

Research outcomes and endpoints

The main outcomes in the study are mental well-being and health-related QOL. The former will be assessed from the Short Warwick Short Warwick Edinburgh Mental Well-being Scale (SWEMWBS) [16–21], which evaluates general well-being through a series of statements about feelings and behaviors experienced over the past week. The instrument comprises seven items, and participants provide responses to each on a discrete scale from 0 (never) to 4 (almost always). The items assess feelings of optimism about the future, being useful, relaxation, effective problem-solving, mental clarity, sociability, and firm decision making. The scores for are summed to produce a total score ranging from 0 to 35, with total raw scores transformed into metric ones using the SWEMWBS conversion table [22]. Although there are no local data for AoNZ, scores of 21–27 are typical for healthy people, with lower scores indicating poorer mental wellbeing and higher ones indicating greater mental well-being.

Health-related QOL will be assessed by the EuroQol Group EQ-5D Visual Analogue Scale (VAS) [23], where participants indicate health state on a continuous scale anchored from 0 (the worst possible health state) to 100 (the best possible health state). The population norm for those aged 18–24 years in AoNZ is 82.4 [24].

Other quantitative variables

Sociodemographic and clinical variables.

Sociodemographic data will include participant age, gender, educational level, self-declared ethnicity (prioritized according to accepted AoNZ ethnicity data protocols [25–27]), relationship status, current employment, living situation, household income, access to information and communications technology. A general index of socioeconomic status will be calculated using the New Zealand Index of Multiple Deprivation (IMD18), which comprises 29 indicators grouped into seven domains of deprivation: employment, income, crime, housing, health, education and access to services [28]. Rurality of domicile will be classified according to the current generic definitions of Statistics NZ, delineating four urban and eight rural categories [29]. Clinical data will include details of dialysis treatment, kidney transplant listing status, and co-morbidity including the Charlson co-morbidity index [30,31].

Alternative measures of quality of life.

The primary assessment of health-related QOL will be supplemented by two other measures. In the first, participants will be assessed from their responses in five domains assessed in the EuqoQol Group EQ-5D-3L: mobility, taking care of oneself, usual activities, pain/discomfort, and anxiety/depression [32]. Levels in each of the domains are assessed from questions with Likert response options, ranging from no issues (Level 1) to severe issues (Level 3). The aggregate state for participants is represented by their 5-digit (5D) code (for example, 11111 signifies no issues in any area). The 5D codes will be then transformed into a single utility index using a validated value set for AoNZ [33–35]. The frequency of any reported problems in the AoNZ population using the EQ-5D-3L is 20% for mobility, 4.4% for self-care, 21.5% for usual activities, 40.8% for pain/discomfort, and 21.2% for anxiety/depression [36].

The second alternative measure is from their responses to the Pediatric Quality of Life Inventory 3.0 End-Stage Renal Disease (PedsQL 3.0 ESRD) [37]. Participants will be assessed from their responses on frequency scales in seven domains (1) General Fatigue (4 items), (2) About My Kidney Disease (5 items assessing participants’ symptomatic burden from swelling, dizziness, headaches, thirst, and muscle cramps), (3) Treatment Problems (4 items assessing the challenges participants face in adhering to their treatment regimen), (4) Family and Peer Interaction (3 items assessing how treatments impact the participants’ relationships with family and friends), (5) Worry (10 items assessing participants’ anxieties regarding their medical condition, including concerns about treatment efficacy, surgeries, long-term illness, hospital stays, blood pressure, and infections), (6) Perceived Physical Appearance (3 items assessing participants’ feelings related to physical appearance, particularly scars and the side effects of medications), and (7) Communication (5 items assessing how comfortable participants feel when communicating with healthcare providers and explaining their illness to others). The total score will also be assessed as the average of all individual item scores within the scales. Of note, assessments for this instrument use reverse scoring, with 0 (never) = 100, 1 (almost never) = 75, 2 (sometimes) = 50, 3 (often) = 25, and 4 (almost always) = 0.

Alternative measures of mental well-being.

Mental well-being in those identifying as Māori will be also assessed using the Hua Oranga tool. This scale was initially developed by Sir Mason Durie and Dr Te Kani Kingi and subsequently adapted by Dr Simon Bennett [38–41]. To ensure cultural relevance, alongside generic measures such as EQ-5D and SWEMWBS, we will employ Hua Oranga, a Māori health outcome measure. The Taha scale represents a holistic approach to well-being, featuring four key domains: “Taha Tinana” focuses on physical health and self-care, “Taha Whānau” emphasizes family relationships and support, “Taha Hinengaro” addresses mental and emotional well-being, and “Taha Wairua” reflects Māori identity and ancestral connections. Collectively, these domains capture the interconnected aspects of physical, emotional, family, and cultural well-being. The instrument presents 5-point Likert response options to evaluate different domains of mental health and well-being that are important in models of health for indigenous AoNZ peoples. Levels range from 1 (strongly disagree) to 5 (strongly agree), and the scores summed to range between 4–20 for each domain (Table 1)

Table 1. Taha item scoring for the Hua Oranga Scale.
Category Score Range Description
Very Low 4-8 Indicates significant challenges in the domain.
Low 9-12 Reflects some challenges but with opportunities for improvement.
High 13-16 Represents a good level of performance or wellbeing in the domain.
Very High 17-20 Highlights strengths and exceptional outcomes in the domain.

The total score for the Hua Oranga Scale is determined by adding up the scores from all four domains, ranging from 16 to 80. We have incorporated two supplementary questions to further explore Māori identity: “Te reo Māori is important to me in my daily life” and “I feel strongly connected to my culture.” These questions are intended to offer a deeper understanding of the individual’s connection to their Māori identity and cultural heritage.

Activities of daily living.

We will explore participants’ ability to manage routine tasks in a purely descriptive manner, focusing on how self-sufficient they are in performing these essential activities without assistance from their caregivers. The Activities of Daily Living (ADL) scale for this study uses a binary scoring system, where a score of 1 indicates that the respondents can perform a specific activity, and a score of 0 represents that they cannot. This approach was applied to four types of ADLs, as described in the book “Activities of Daily Living” [42–44]. The categories comprise: basic ADLs. (dressing, eating, toileting, bathing, and mobility); instrumental ADLs (everyday tasks that involve using tools to manage basic responsibilities, like cooking meals, handling phone calls, writing, typing, and managing money); vocational ADLs (activities related to employment or schoolwork); non-vocational ADLs (activities for fun, such as hobbies, leisure activities, and personal interests).

Physical activity.

Participants’ engagement in physical activities will be assessed using the Rapid Assessment of Physical Activity (RAPA) instrument [45,46]. The first section, RAPA 1, includes seven items that inquire about the frequency and intensity of physical activity, requiring binary responses scored as 1 if the respondents can perform at that activity level, and a score of 0 if they cannot. The total score ranges from 1 (infrequent or no physical activity) to 7 (20 + minutes of intense physical activity three or more times weekly). The RAPA 1 scale categorizes overall physical activity into three levels (light, moderate, vigorous). The second section, RAPA 2, asks about attempts to enhance muscle strength and flexibility by engaging in specified exercises.

Although RAPA was originally validated for adults, particularly older adults [47], pilot testing in the current study demonstrated that youth participants could easily understand and respond to RAPA items. To strengthen validity, RAPA responses will be triangulated with the physical functioning subscale of the Pediatric Quality of Life Inventory (PedsQL), allowing cross-verification of self-reported physical activity. Adolescents are advised to engage in at least 60 minutes of moderate to vigorous physical activity daily, including activities that strengthen muscles and bones at least three times per week [47]. Given these guidelines, they might be expected to achieve the maximum RAPA scores, although this is not particularly borne out in available studies. In the largest study using RAPA in healthy youths, 70% of 555 Spanish university students were categorized as sedentary or inactive, 27% moderately active, and 3% active [48]. In contrast, the largest study assessing RAPA in a multinational cohort of dialysis patients with a mean age of 63.4 years showed that 37% of the 5763 people were categorized as sedentary or inactive, 44% as moderately active, and 19% active [49]. There are no studies using the RAPA instrument in AoNZ, in either healthy youths or dialysis patients. The RAPA will therefore be treated as an exploratory measure.

Self-efficacy.

Self-efficacy will be assessed from the General Self-Efficacy Scale (GSES) instrument [50]. The GSES has 10 items with 4-point Likert response options and evaluates a person’s belief in their capability to handle and deal with different circumstances. Scoring is summative with a total score that can vary between 10 and 40. Greater scores indicate higher levels of self-efficacy, showing more confidence in handling challenges and completing tasks. Evidence supporting construct validity of the GSES indicate strong connections with emotions, optimism, and job satisfaction [51]. This implies that people who believe in their capabilities are more likely to have better experiences with positive factors. The GSES is inversely related to depression, stress, and anxiety, showing that increased self-efficacy is linked to reduced levels of these adverse mental conditions.

Social anxiety.

We will explore this construct using the DSM-5 Social Anxiety Disorder Severity Scale (SAD-D) [52]. In this scale, each item is scored using a discrete 5-point frequency scale ranging from 0 (never) and 4 (all the time). The total score is summative and ranges between 0–40, with higher scores indicating more severe anxiety. A variety of cut-off values have been suggested, and exploration of this recently developed scale is ongoing. It has been reported that individuals seeking help for social anxiety had a mean SAD-D score of 25.7 [53], although a clinically useful cut-off for assessments has recently been suggested at 19 [54].

Depression.

Depressive symptoms will be assessed using the Center for Epidemiological Studies Depression Scale for Children (CES-DC). The instrument comprises 20 items using a 4-point Likert scale, with scores ranging 0 (not at all) to 3 (a lot). Reverse scoring is required for some positively framed items. The total score is summative and ranges between 0–60, with higher scores indicating increased chance of depression. A well accepted cut-off has been established by the developers, namely Weissman et al, whereby a score >15 suggests presence of depressive symptoms in a young adult requiring additional evaluation [55]. Data in dialysis populations suggest that about quarter to half of people screened using this tool are likely to have results indicating depression [56–59].

Health literacy.

We will assess health literacy using a three-item instrument. The single items within the instrument have each been separately validated against definitive instruments [60,61], and the combination used as a single measure of health literacy [62,63]. Reversing the first item, scores of nine or above on the combined scale indicate suboptimal health literacy. Of note, this scale only assesses the ability of patients to locate, interpret and apply health information (classically defined health literacy) [64], rather than the extent to which health systems provide accessible comprehensible information (so-called health information fluency) [65,66].

Open-ended questions.

Free text comments will be sought from participants around situations causing social anxiety and other factors of general concern and these will be analyzed using both inductive and deductive qualitative content analysis [67].The qualitative data will be coded and analyzed by two members of the research team and any discrepancies in coding with be resolved via consensus.

Data analysis

We will use structural equations models (SEM) to explore possible relationship between physical and psychometric predictors and the outcomes of interest, namely mental wellbeing and health related quality of life. There are no existing conceptual models linking the psychosocial factors in this study to the outcomes, and exploratory rather than confirmatory modelling will be performed using variance-based SEM [68–71]. We chose this analytical technique over traditional covariance-based structural equation modelling, since it is more often used for prediction and theory development, as opposed to the latter which is more used for theory testing and confirmation. In variance-based SEM, the psychometric variables in our survey will be used to generate weighted composites, and paths estimated between the composites in a manner broadly similar to multiple linear regression. Because of the likely small sample size and the exploratory nature of the modelling, we will not perform rigorous assessments of items within the instruments for internal validity through confirmatory measurement models, and scores from the survey items will be used as they were originally published.

For each of the two outcomes of interest, the following will be explored as mediating or exogenous variables: depression as defined by the CES-DC scale, self-efficacy defined as defined by the GSE scale, social phobia as defined by the SAD-D scale, physical activity defined as defined by the RAPA scale, and the constructs from the PedsQL 3.0 QOL End Stage Renal Disease Module, namely general fatigue, kidney disease symptoms, treatment problems, family and peer Interactions, worry about medical care, perceived physical appearance, and communication with medical/ nursing/ allied staff. Simple correlational analysis will be used to identify the key scales associating either positively or negatively with each of the two outcomes of interest, and these will be used by the investigators to create plausible structural relationships, derived from both the literature and their own cumulative clinical experience. Final model structures will be dictated by the aims and objectives described above, and refined according to model fit, face-validity in a clinical sense, and the presence and extent of support for a given model structure from other published research.

Depending on the pattern of survey responses, we may proceed to cluster analysis and descriptive profiling as secondary post hoc activities, with or without latent class analyses looking for subgroups that we cannot cluster using manifest variables. The benefit of this approach will arise from determine demographic and behavioral variables differ across the clusters, which might in turn create further actionable insights within discrete respondent groups of our population. For example, the difference in self-efficacy and other characteristics can be explored in clusters defined by dependent and independent dialysis to look for levers to improve self-efficacy or improve uptake of home dialysis, depending on the respondent results.

Discussion

At the current time, most physical and psychological initiatives in this group focus on medical rehabilitation and generic coping acceptance strategies, respectively. In general, there is less emphasis on specific interventions that focus on developing youth physical and social skills using a modern educational science lens. Such interventions might create safe, positive problem-solving skills for young people, especially if learning is embedded in realistic contexts with authentic tasks [72,73].

The challenges encountered by youth on dialysis in AoNZ and elsewhere are significant and different from their adult counterparts. In AoNZ, structural racism and health inequities within the system disproportionately disadvantage Māori and Pacific youths, contributing to challenges in quality of life, psychological distress, and increased social limitations compared to their European counterparts [74,75]. This systemic bias is evident in the fact that 50% of the 154 youths on dialysis in AoNZ between 1 January 2000 and 31 December 2014 were from these ethnic groups.

We expect our study to cast light on the presence and extent of physical and psychosocial needs of youth on dialysis and suggest specific areas for intervention.

Data Availability

Authors agree to make data and materials supporting the results or analyses presented in their paper available upon reasonable request. It is up to the authors to determine whether a request is reasonable. Several factors will be considered in evaluating requests: • Legitimacy of scientific purpose: requests will be viewed more favorably if the intention is replication, meta-analysis, secondary analysis, or educational use. • Requester credentials: requests from researchers at recognized institutions with relevant expertise will be viewed more favorably. • Feasibility and burden: reasonable requests should not impose excessive work on the authors. • Ethical and legal constraints: certain data containing sensitive information have restrictions on sharing, as specified in data use agreements and ethics / IRB approvals. In particular, as a matter of national policy in Aotearoa New Zealand (AoNZ), there is a relative prohibition around sending Māori research data overseas consistent with the principles of Māori self-determination and control over data about their communities, rooted in Te Tiriti o Waitangi (the Treaty of Waitangi) and as specified in the (AoNZ) Data and Statistics Act 2022. Sharing of such data would require an evaluation from the national (AoNZ) Health and Disability Ethics Committee and as well as IRBs of all the participating hospitals, who will decide whether it is possible enforce AoNZ rules and norms pertaining to such data, including but not limited to: (1) whether the overseas jurisdictions have comparable data protection safeguards to AoNZ; (2) whether there will be culturally appropriate representation on overseas governance committees to ensure that the data are handled in culturally appropriate ways with a good understanding of the NZ Māori community that the data relate to. • Specificity: only specific requests for variables relevant to well-defined research question will be considered. • Timing: requests made shortly after publication will be considered whereas those made a substantial amount of time later may not be possible when authors have moved on or data storage has lapsed. • Reciprocity and collaboration: offers of collaboration or data sharing in return will be viewed more favorably than one-sided requests. Requests should be directed to the corresponding author and to hdecs@health.govt.nz quoting ethics reference: 21/NTB/125.

Funding Statement

University of Auckland Open Access Grant as part of general PhD funding.

References

  • 1.Assadi F. The growing epidemic of chronic kidney disease: preventive strategies to delay the risk for progression to ESRD. Primordial prevention of non communicable disease. 2019:57–9. [DOI] [PubMed]
  • 2.Nair N, Prashant Kadatane S, Yaacoub RM, Sandhu JM, Bhavaraju S, Raina R. Challenges and unique considerations of adolescents with chronic kidney disease. Acta Paediatr. 2023;112(6):1165–76. doi: 10.1111/apa.16752 [DOI] [PubMed] [Google Scholar]
  • 3.Tsutsui H. Chronic Kidney Disease. In: Kondo K, editor. Social Determinants of Health in Non-communicable Diseases: Case Studies from Japan. Singapore: Springer Singapore. 2020. p. 61–72. [Google Scholar]
  • 4.Incidence of renal replacement therapy for end stage kidney disease. ANZDATA Registry. Adelaide, Australia: Australia and New Zealand Dialysis and Transplant Registry. 2021. [Google Scholar]
  • 5.Marshall MR, Polkinghorne KR, Kerr PG, Hawley CM, Agar JWM, McDonald SP. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations. Am J Kidney Dis. 2016;67(4):617–28. doi: 10.1053/j.ajkd.2015.09.025 [DOI] [PubMed] [Google Scholar]
  • 6.Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. 2012. [DOI] [PMC free article] [PubMed]
  • 7.Wyld ML, De La Mata NL, Hedley J, Kim S, Kelly PJ, Webster AC. Life Years Lost in Children with Kidney Failure: A Binational Cohort Study with Multistate Probabilities of Death and Life Expectancy. J Am Soc Nephrol. 2023;34(6):1057–68. doi: 10.1681/ASN.0000000000000118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Clementi MA, Zimmerman CT. Psychosocial considerations and recommendations for care of pediatric patients on dialysis. Pediatr Nephrol. 2020;35(5):767–75. doi: 10.1007/s00467-019-04227-5 [DOI] [PubMed] [Google Scholar]
  • 9.Hamilton AJ, Caskey FJ, Casula A, Ben-Shlomo Y, Inward CD. Psychosocial Health and Lifestyle Behaviors in Young Adults Receiving Renal Replacement Therapy Compared to the General Population: Findings From the SPEAK Study. Am J Kidney Dis. 2019;73(2):194–205. doi: 10.1053/j.ajkd.2018.08.006 [DOI] [PubMed] [Google Scholar]
  • 10.Lewis H, Marks SD. Differences between paediatric and adult presentation of ESKD in attainment of adult social goals. Pediatr Nephrol. 2014;29(12):2379–85. doi: 10.1007/s00467-014-2864-x [DOI] [PubMed] [Google Scholar]
  • 11.Tjaden LA, Grootenhuis MA, Noordzij M, Groothoff JW. Health-related quality of life in patients with pediatric onset of end-stage renal disease: state of the art and recommendations for clinical practice. Pediatr Nephrol. 2016;31(10):1579–91. doi: 10.1007/s00467-015-3186-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.International Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use (ICH) Integrated addendum to ICH E6 (R1): guideline for good clinical practice E6 (R2). 2015.
  • 13.Andrews LM, Allen H, Sheppard ZA, Baylis G, Wainwright TW. More than just ticking a box…how patient and public involvement improved the research design and funding application for a project to evaluate a cycling intervention for hip osteoarthritis. Res Involv Engagem. 2015;1:13. doi: 10.1186/s40900-015-0013-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Foster M, Fergusson DA, Hawrysh T, Presseau J, Kekre N, Schwartz S, et al. Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials. Res Involv Engagem. 2020;6:61. doi: 10.1186/s40900-020-00230-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.United Nations. Report of the Advisory Committee for the International Youth Year 1981. [cited 2025 Sept 25]. Available from: https://undocs.org/en/A/36/215 [Google Scholar]
  • 16.McKay MT, Andretta JR. Evidence for the Psychometric Validity, Internal Consistency and Measurement Invariance of Warwick Edinburgh Mental Well-being Scale Scores in Scottish and Irish Adolescents. Psychiatry Res. 2017;255:382–6. doi: 10.1016/j.psychres.2017.06.071 [DOI] [PubMed] [Google Scholar]
  • 17.Ng Fat L, Scholes S, Boniface S, Mindell J, Stewart-Brown S. Evaluating and establishing national norms for mental wellbeing using the short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS): findings from the Health Survey for England. Qual Life Res. 2017;26(5):1129–44. doi: 10.1007/s11136-016-1454-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ringdal R, Bradley Eilertsen M-E, Bjørnsen HN, Espnes GA, Moksnes UK. Validation of two versions of the Warwick-Edinburgh Mental Well-Being Scale among Norwegian adolescents. Scand J Public Health. 2018;46(7):718–25. doi: 10.1177/1403494817735391 [DOI] [PubMed] [Google Scholar]
  • 19.Vaingankar JA, Abdin E, Chong SA, Sambasivam R, Seow E, Jeyagurunathan A, et al. Psychometric properties of the short Warwick Edinburgh mental well-being scale (SWEMWBS) in service users with schizophrenia, depression and anxiety spectrum disorders. Health Qual Life Outcomes. 2017;15(1):153. doi: 10.1186/s12955-017-0728-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bartram DJ, Sinclair JM, Baldwin DS. Further validation of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) in the UK veterinary profession: Rasch analysis. Qual Life Res. 2013;22(2):379–91. doi: 10.1007/s11136-012-0144-4 [DOI] [PubMed] [Google Scholar]
  • 21.Clarke A, Friede T, Putz R, Ashdown J, Martin S, Blake A, et al. Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessment. BMC Public Health. 2011;11:487. doi: 10.1186/1471-2458-11-487 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Stewart-Brown S, Tennant A, Tennant R, Platt S, Parkinson J, Weich S. Internal construct validity of the Warwick-Edinburgh mental well-being scale (WEMWBS): a Rasch analysis using data from the Scottish health education population survey. Health and quality of life outcomes. 2009;7:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis. 2012;78(3):155–9. doi: 10.4081/monaldi.2012.121 [DOI] [PubMed] [Google Scholar]
  • 24.Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. 2014. [PubMed]
  • 25.Cormack D. Making ethnicity data count. Best Pract J. 2007;9:44–6. [Google Scholar]
  • 26.New Zealand Ministry of Health. HISO 10001: 2017 ethnicity data protocols. Wellington: Ministry of Health. 2017. [Google Scholar]
  • 27.Tan L, Blakely T, Atkinson J. Ethnic counts on mortality and census data 2001-06: New Zealand census-mortality study update. N Z Med J. 2010;123(1320):37–44. [PubMed] [Google Scholar]
  • 28.Exeter DJ, Zhao J, Crengle S, Lee A, Browne M. The New Zealand Indices of Multiple Deprivation (IMD): A new suite of indicators for social and health research in Aotearoa, New Zealand. PLoS One. 2017;12(8):e0181260. doi: 10.1371/journal.pone.0181260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Stats NZ. Urban accessibility–methodology and classification. Wellington (NZ): Government of New Zealand. 2020. [Google Scholar]
  • 30.Ashton T, Marshall MR. The organization and financing of dialysis and kidney transplantation services in New Zealand. Int J Health Care Finance Econ. 2007;7(4):233–52. doi: 10.1007/s10754-007-9023-x [DOI] [PubMed] [Google Scholar]
  • 31.Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. doi: 10.1016/0021-9681(87)90171-8 [DOI] [PubMed] [Google Scholar]
  • 32.Szende A, Janssen B. Socio-demographic Indicators Based on EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective based on EQ-5D. Dordrecht (NL): Springer. 2013. p. 37–46. doi: 10.1007/978-94-007-7596-1_5 [DOI] [Google Scholar]
  • 33.Devlin NJ, Hansen P, Kind P, Williams A. Logical inconsistencies in survey respondents’ health state valuations -- a methodological challenge for estimating social tariffs. Health Econ. 2003;12(7):529–44. doi: 10.1002/hec.741 [DOI] [PubMed] [Google Scholar]
  • 34.EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi: 10.1016/0168-8510(90)90421-9 [DOI] [PubMed] [Google Scholar]
  • 35.Szende A, Oppe M, Devlin N. EQ-5D value sets: inventory, comparative review and user guide. EuroQol Group Monographs. 2007. [Google Scholar]
  • 36.Devlin N, Hansen P, Herbison P. Variations in self-reported health status: results from a New Zealand survey. N Z Med J. 2000;113(1123):517–20. [PubMed] [Google Scholar]
  • 37.Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800–12. doi: 10.1097/00005650-200108000-00006 [DOI] [PubMed] [Google Scholar]
  • 38.Bennett STM. Te Huanga O Te Ao Māori: Cognitive Behavioural Therapy for Māori Clients with Depression: Development and Evaluation of a Culturally Adapted Treatment Programme: a Dissertation Presented in Partial Fulfilment of the Requirements for the Degree of Doctor of Philosophy in Psychology at Massey University, Wellington, New Zealand: Massey University, Wellington; 2009.
  • 39.Harwood M, Weatherall M, Talemaitoga A, Barber P, Gommans J, Taylor W. An assessment of the Hua Oranga outcome instrument and comparison to other outcome measures in an intervention study with Māori and Pacific people following stroke. 2012. [PubMed]
  • 40.Kingi TKR, Durie MH. Hua oranga: A Māori measure of mental health outcomes. Ministry of Health. 2000. [Google Scholar]
  • 41.McLachlan A. Whāngaihia te hua o oranga ki ō tatou whānau whānui: Ko te tikanga o te whakamahinga o Hua Oranga.Wellington: Te Rau Ora. Te Rau Ora. 2022.
  • 42.Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10(1):20–30. doi: 10.1093/geront/10.1_part_1.20 [DOI] [PubMed] [Google Scholar]
  • 43.Tri YDY, Cipta NAN, Budhi BW, Sahadi SH. Activity daily living (ADL) of young people with intellectual disabilities. In: International Conference on Diversity and Disability Inclusion in Muslim Societies (ICDDIMS 2017), 2017. [Google Scholar]
  • 44.McCarthy K. Activities of Daily Living. Therapro Incorporated: Framington, MA, United States, 1993.
  • 45.Logan J, Kim S-S, Lee M, Yeo S. Anxiety and physical inactivity: breaking the vicious circle. Mental Health Practice. 2018;21(6):15–9. doi: 10.7748/mhp.2018.e1267 [DOI] [Google Scholar]
  • 46.Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis. 2006;3(4):A118. [PMC free article] [PubMed] [Google Scholar]
  • 47.Miszory EV, Makai A, Pakai A, Járomi M. Cross-cultural adaptation and validation of the rapid assessment of physical activity questionnaire (RAPA) in Hungarian elderly over 50 years. BMC sports science, medicine and rehabilitation. 2022;14(1):131. [DOI] [PMC free article] [PubMed]
  • 48.Tárraga López PJ, Tárraga Marcos A, Panisello JM, Herencia Carbayo JA, Tárraga Marcos ML, López-Gil JF. Physical activity and its association with Mediterranean diet patterns among Spanish university students. Nutr Hosp. 2022;39(3):603–9. doi: 10.20960/nh.03892 [DOI] [PubMed] [Google Scholar]
  • 49.Lopes AA, Lantz B, Morgenstern H, Wang M, Bieber BA, Gillespie BW, et al. Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS. Clin J Am Soc Nephrol. 2014;9(10):1702–12. doi: 10.2215/CJN.12371213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Schwarzer R. Generalized self-efficacy scale. Nfer-Nelson. 1995. [Google Scholar]
  • 51.Abu Sharour L, Bani Salameh A, Suleiman K, Subih M, El-Hneiti M, Al-Hussami M, et al. Nurses’ Self-Efficacy, Confidence and Interaction With Patients With COVID-19: A Cross-Sectional Study. Disaster Med Public Health Prep. 2022;16(4):1393–7. doi: 10.1017/dmp.2021.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Craske M, Wittchen U, Bogels S, Stein M, Andrews G, Lebeu R. Severity Measure for Social Anxiety Disorder (Social Phobia)—Child Age 11–17. 2013.
  • 53.LeBeau RT, Mesri B, Craske MG. The DSM-5 social anxiety disorder severity scale: Evidence of validity and reliability in a clinical sample. Psychiatry Res. 2016;244:94–6. doi: 10.1016/j.psychres.2016.07.024 [DOI] [PubMed] [Google Scholar]
  • 54.Rice K, Schutte NS, Rock AJ, Murray CV. Structure, validity and cut-off scores for the APA emerging measure: DSM-5 social anxiety disorder severity scale (SAD-D). J Depress Anxiety. 2021;10(406):2167–1044. [Google Scholar]
  • 55.Weissman MM, Orvaschel H, Padian N. Center for Epidemiological Studies Depression Scale for Children. 2013. [Google Scholar]
  • 56.Agganis BT, Weiner DE, Giang LM, Scott T, Tighiouart H, Griffith JL, et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2010;56(4):704–12. doi: 10.1053/j.ajkd.2010.04.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group, Vecchio M, Palmer S, De Berardis G, Craig J, Johnson D, et al. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012;27(6):2479–88. doi: 10.1093/ndt/gfr635 [DOI] [PubMed] [Google Scholar]
  • 58.Lopes MB, Silva LF, Lopes GB, Penalva MA, Matos CM, Robinson BM, et al. Additional contribution of the malnutrition–inflammation score to predict mortality and patient-reported outcomes as compared with its components in a cohort of African descent hemodialysis patients. Journal of Renal Nutrition. 2017;27(1):45–52. [DOI] [PubMed] [Google Scholar]
  • 59.Senanayake S, Mahesh PKB, Gunawardena N, Graves N, Kularatna S. Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country. PLoS One. 2019;14(6):e0211604. doi: 10.1371/journal.pone.0211604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Brice JH, Foster MB, Principe S, Moss C, Shofer FS, Falk RJ, et al. Single-item or two-item literacy screener to predict the S-TOFHLA among adult hemodialysis patients. Patient Educ Couns. 2014;94(1):71–5. doi: 10.1016/j.pec.2013.09.020 [DOI] [PubMed] [Google Scholar]
  • 61.Jain D, Sheth H, Bender FH, Weisbord SD, Green JA. Evaluation of a single-item screening question to detect limited health literacy in peritoneal dialysis patients. Adv Perit Dial. 2014;30:27–30. [PubMed] [Google Scholar]
  • 62.Aspden T, Wolley MJ, Ma TM, Rajah E, Curd S, Kumar D, et al. Understanding barriers to optimal medication management for those requiring long-term dialysis: rationale and design for an observational study, and a quantitative description of study variables and data. BMC Nephrol. 2015;16:102. doi: 10.1186/s12882-015-0097-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Marshall MR, Curd S, Kennedy J, Khatri D, Lee S, Pireva K, et al. Structural Equation Modelling to Identify Psychometric Determinants of Medication Adherence in a Survey of Kidney Dialysis Patients. Patient Prefer Adherence. 2024;18:855–78. doi: 10.2147/PPA.S454248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Institute of Medicine (US) Committee on Health Literacy. Health Literacy: A Prescription to End Confusion. Nielsen-Bohlman L, Panzer AM, Kindig DA, editors. Washington (DC): National Academies Press (US); 2004. [PubMed] [Google Scholar]
  • 65.Ancker JS, Grossman LV, Benda NC. Health Literacy 2030: Is It Time to Redefine the Term?. J Gen Intern Med. 2020;35(8):2427–30. doi: 10.1007/s11606-019-05472-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.The Department of Health and Human Services (HHS). Solicitation for written comments on updated health literacy definition for healthy people 2030. Fed Reg. 2019;84(107):25817–8. https://www.federalregister.gov/d/2019-11571 [Google Scholar]
  • 67.Graneheim UH, Lindgren B-M, Lundman B. Methodological challenges in qualitative content analysis: A discussion paper. Nurse Educ Today. 2017;56:29–34. doi: 10.1016/j.nedt.2017.06.002 [DOI] [PubMed] [Google Scholar]
  • 68.Hair JF, Matthews LM, Matthews RL, Sarstedt M. PLS-SEM or CB-SEM: updated guidelines on which method to use. IJMDA. 2017;1(2):107. doi: 10.1504/ijmda.2017.087624 [DOI] [Google Scholar]
  • 69.Hair JF, Risher JJ, Sarstedt M, Ringle CM. When to use and how to report the results of PLS-SEM. EBR. 2019;31(1):2–24. doi: 10.1108/ebr-11-2018-0203 [DOI] [Google Scholar]
  • 70.Hair JF, Sarstedt M, Hopkins L, G. Kuppelwieser V. Partial least squares structural equation modeling (PLS-SEM). European Business Review. 2014;26(2):106–21. doi: 10.1108/ebr-10-2013-0128 [DOI] [Google Scholar]
  • 71.Venturini S, Mehmetoglu M. plssem: A Stata Package for Structural Equation Modeling with Partial Least Squares. J Stat Soft. 2019;88(8). doi: 10.18637/jss.v088.i08 [DOI] [Google Scholar]
  • 72.Bada SO, Olusegun S. Constructivism learning theory: A paradigm for teaching and learning. Journal of Research & Method in Education. 2015;5(6):66–70. [Google Scholar]
  • 73.Caine RN, Caine G. Making connections: teaching and the human brain. 1991. [Google Scholar]
  • 74.Gurney J, Stanley J, Sarfati D. The inequity of morbidity: Disparities in the prevalence of morbidity between ethnic groups in New Zealand. J Comorb. 2020;10:2235042X20971168. doi: 10.1177/2235042X20971168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Harris R, Li C, Stanley J, King PT, Priest N, Curtis E, et al. Racism and Health Among Aotearoa New Zealand Young People Aged 15–24 years: Analysis of Multiple National Surveys. Journal of Adolescent Health. 2024;75(3):416–25. doi: 10.1016/j.jadohealth.2024.04.021 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Hansani Madushika Abeywickrama

26 Nov 2025

Dear Dr. Marshall,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 10 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Hansani Madushika Abeywickrama, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“University of Auckland Open Access Grant as part of general PhD funding”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information .

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments :

Thank you for submitting this important protocol examining the health and psychosocial outcomes of youths receiving dialysis. Both reviewers agree that the study addresses a notable gap and has the potential to make a meaningful contribution to nephrology research. Please revise the manuscript addressing the points raised by reviewers. Ensure clarity, consistency, and methodological appropriateness throughout the updated protocol. We look forward to receiving a carefully revised version.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

Reviewer #1: This study addresses a vital gap in the care of youths on dialysis. The data will be highly relevant to the nephrology community. However, the current statistical plan (SEM) is a significant weakness given the limited patient population. Shifting the analytical focus toward clustering and descriptive profiling would make the protocol scientifically robust.

Nevertheless, there is a real need and benefit to collecting comprehensive structured data within this unstudied population and PLOS ONE should support the proposal.

Note to the Editor: If this methodology paper is accepted, PLOS ONE should be the venue for the results of the study to ensure the complete research cycle is available in one place

Reviewer #2: Thank you for submitting this protocol for a study in an important population

A few comments

The word 'youth' throughout sometimes needs to be plural wonder if young adult or young adults might be better

The PPIE section there is sentence started and not completed

Just some clarity on exclusion criteria as further on you state has a 'documented cognitive or physical impairment that prevents self-completion, assistance from a parent or caregiver will be permitted'- just need to be clear why is this different to what is described as severe in the exclusion criteria

An extensive list of outcome measures including clinical variables just a question as this is for people on dialysis have you considered any questions on their role within their dialysis treatment relating to self efficacy?

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Attachment

Submitted filename: PONE-D-25-52324 Review TB.docx

pone.0340006.s001.docx (19KB, docx)
PLoS One. 2026 Feb 19;21(2):e0340006. doi: 10.1371/journal.pone.0340006.r002

Author response to Decision Letter 1


26 Nov 2025

Hansani Madushika Abeywickrama, Ph.D.

Academic Editor

PLOS ONE

Dear Dr Abeywickrama

Response to Reviewers

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you, we have made changes in style to comply with requirements.

2. Thank you for stating the following financial disclosure:

“University of Auckland Open Access Grant as part of general PhD funding”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Thanks you we have done this.

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Thank you. We apricate that the ambiguity in "reasonable request" has been criticized in open science discussions, and that many advocate for clearer data sharing commitments like public repository deposits to avoid gatekeeping. We have clarified the restrictions on data sharing, which we have expanded upon on page 17 of the manuscript. Of note, some of these restrictions are legal. See below:

#############################START##############################

Authors agree to make data and materials supporting the results or analyses presented in their paper available upon reasonable request. It is up to the authors to determine whether a request is reasonable. Several factors will be considered in evaluating requests:

• Legitimacy of scientific purpose: requests will be viewed more favorably if the intention is replication, meta-analysis, secondary analysis, or educational use.

• Requester credentials: requests from researchers at recognized institutions with relevant expertise will be viewed more favorably.

• Feasibility and burden: reasonable requests should not impose excessive work on the authors

• Ethical and legal constraints: certain data containing sensitive information have restrictions on sharing, as specified in data use agreements and ethics / IRB approvals. In particular, as a matter of national policy in Aotearoa New Zealand, there is a relative prohibition around sending Māori research data overseas consistent with the principles of Māori self-determination and control over data about their communities, rooted in Te Tiriti o Waitangi (the Treaty of Waitangi) and as specified in the (NZ) Data and Statistics Act 2022. Sharing of such data would require an evaluation from the national (NZ) Health and Disability Ethics Committee and as well as IRBs of all the participating hospitals, who will decide whether it is possible enforce NZ rules and norms pertaining to such data, including but not limited to: (1) whether the overseas jurisdictions have comparable data protection safeguards to NZ; (2) whether there will be culturally appropriate representation on overseas governance committees to ensure that the data are handled in culturally appropriate ways with a good understanding of the NZ Māori community that the data relate to

• Specificity: only specific requests for variables relevant to well-defined research question will be considered

• Timing: requests made shortly after publication will be considered whereas those made a substantial amount of time later may not be possible when authors have moved on or data storage might have lapsed.

#############################FINISH##############################

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

N/A

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

N/A

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Thank you, and checked

Reviewer #1comments:

The current statistical plan (SEM) is a significant weakness given the limited patient population. Shifting the analytical focus toward clustering and descriptive profiling would make the protocol scientifically robust.

Thank you, this is a very useful and helpful comment.

Firstly, we think a structural / causal analysis is warranted to create actionable insights with a likely benefit in idealistically a deterministic manner (but of course a practically stochastic one). We have been clear that we are using PLS-SEM rather than CB-SEM. The former is very forgiving to smaller datasets and would allow reasonable statistical inference in this sample, in our estimation. The corresponding author has several publications using this methodology in samples with n < 100, and is confident of being able to obtain at least a signal of findings if they are there to be found. The overall chance of model convergence and statistical significance is hampered by the small sample size, of course, but this leads to Type II rather than Type I errors. The group is happy to work within this constraint.

The suggestion around cluster analysis +/- hierarchical clustering with dendrograms +/- decision tree methods like CHAID or CART etc is a great idea, although we did not specify this analysis in our statistical analysis plan, let alone details such as the number of clusters in advance. This will be a great post hoc study and we might include latent class analysis as well, in case there are subgroups that we cannot identify a priori, but which become clear based on patterns of survey responses. Once we have those clusters mapped, we will determine how demographic and behavioral responses differ across them. Such an approach might create further actionable insights within discrete respondent groups in our sample.

We have added a statement of intent around these extended analyses in the discussion on Page 15.

Reviewer #1comments:

The word 'youth' throughout sometimes needs to be plural wonder if young adult or young adults might be better

Thank you. We too have struggled with this at times. “Youth" can be a singular noun, referring to one young person. It can also be used collectively for a group of young people, as an uncountable noun. We have gone through the paper and made sure that “youth” is used as a singular noun or used collectively, and made sure that we have used the term “youths” for more than one person who all happen to fit the conceptual definition.

Speaking of which, "youth" is an official demographic term. For statistical and research purposes, the UN defines 'youth' as persons between ages 15 and 24, a definition established in 1981 during preparations for the International Youth Year. All UN statistics on youth are based on this definition, as reflected in annual yearbooks on demography, education, employment, and health United Nations. WHO defines adolescents as individuals between 10 and 19 years, young people as those aged 10-24, and youth as those aged 15-24.

We feel that we should be clear about which definition of younger persons we are studying, and introducing the term “young adults” we think would create confusion.

The PPIE section there is sentence started and not completed

Thank you, this error has been corrected.

Just some clarity on exclusion criteria as further on you state has a 'documented cognitive or physical impairment that prevents self-completion, assistance from a parent or caregiver will be permitted'- just need to be clear why is this different to what is described as severe in the exclusion criteria

Thank you for this. The issue is not really one that pertains to communication difficulties, but rather pertains to those patients with severe functional difficulties or disabilities that are not appropriate for assessment by the survey instrument. The verbiage in the paper was carried through from the protocol and was clearly an error. We have corrected this in the manuscript on page 7.

An extensive list of outcome measures including clinical variables just a question as this is for people on dialysis have you considered any questions on their role within their dialysis treatment relating to self efficacy?

Thank you for this great suggestion. We had not though of this, and will triangulate and correlate GSES with dependent versus independent modalities of dialysis. This maybe an additional paper and would suit a clustering and descriptive profiling paper which we should do as a post-hoc exercise. We have added statement of intent around these extended analyses in the discussion on Page 15-16.

Attachment

Submitted filename: Response to reviewers.docx

pone.0340006.s003.docx (24KB, docx)

Decision Letter 1

Hansani Madushika Abeywickrama

15 Dec 2025

<p>Protocol for the ‘Exploration of Mental Well-Being, Health-Related Quality of Life, and Psychosocial Outcomes in Youths on Dialysis in New Zealand: A Cross-Sectional Methods Study’

PONE-D-25-52324R1

Dear Dr. Marshall,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hansani Madushika Abeywickrama, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

Reviewer #1: The authors have addressed the questions raised. They acknowledge the limitations of their project, which, in my opinion, are outweighed by the collective interest of the approach for the discipline. This article could therefore be relevant for publication in PLOS.

Reviewer #2: Thank you for taking time to address the comments I have no further comments to add, good luck with the study

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Hansani Madushika Abeywickrama

PONE-D-25-52324R1

PLOS One

Dear Dr. Marshall,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Hansani Madushika Abeywickrama

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PONE-D-25-52324 Review TB.docx

    pone.0340006.s001.docx (19KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0340006.s003.docx (24KB, docx)

    Data Availability Statement

    Authors agree to make data and materials supporting the results or analyses presented in their paper available upon reasonable request. It is up to the authors to determine whether a request is reasonable. Several factors will be considered in evaluating requests: • Legitimacy of scientific purpose: requests will be viewed more favorably if the intention is replication, meta-analysis, secondary analysis, or educational use. • Requester credentials: requests from researchers at recognized institutions with relevant expertise will be viewed more favorably. • Feasibility and burden: reasonable requests should not impose excessive work on the authors. • Ethical and legal constraints: certain data containing sensitive information have restrictions on sharing, as specified in data use agreements and ethics / IRB approvals. In particular, as a matter of national policy in Aotearoa New Zealand (AoNZ), there is a relative prohibition around sending Māori research data overseas consistent with the principles of Māori self-determination and control over data about their communities, rooted in Te Tiriti o Waitangi (the Treaty of Waitangi) and as specified in the (AoNZ) Data and Statistics Act 2022. Sharing of such data would require an evaluation from the national (AoNZ) Health and Disability Ethics Committee and as well as IRBs of all the participating hospitals, who will decide whether it is possible enforce AoNZ rules and norms pertaining to such data, including but not limited to: (1) whether the overseas jurisdictions have comparable data protection safeguards to AoNZ; (2) whether there will be culturally appropriate representation on overseas governance committees to ensure that the data are handled in culturally appropriate ways with a good understanding of the NZ Māori community that the data relate to. • Specificity: only specific requests for variables relevant to well-defined research question will be considered. • Timing: requests made shortly after publication will be considered whereas those made a substantial amount of time later may not be possible when authors have moved on or data storage has lapsed. • Reciprocity and collaboration: offers of collaboration or data sharing in return will be viewed more favorably than one-sided requests. Requests should be directed to the corresponding author and to hdecs@health.govt.nz quoting ethics reference: 21/NTB/125.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES